Professor Brian MacCraith:

The assurances we had received indicated 1.4 million doses across AstraZeneca, Pfizer and Moderna. Naturally, the simple calculation is to say they are all due to those vaccines and that leads to 700,000 people being vaccinated. However, as we have learned in recent days, AstraZeneca has indicated a significant drop at this stage. Currently, that 1.4 million doses has reduced to just above 1.1 million doses while we await the outcome of the negotiations between AstraZeneca and the European Commission.